Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary Option Care Health to Participate in Upcoming Investor Conference
BANNOCKBURN, Ill. , Aug. 31, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the Morgan Stanley 21st Annual Global Healthcare Conference,
Toggle Summary Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2023
BANNOCKBURN, Ill. , July 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2023
Toggle Summary Option Care Health to Announce Second Quarter 2023 Financial Results and Host Conference Call
BANNOCKBURN, Ill. , July 06, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30,
Toggle Summary Option Care Health Confirms Termination of Merger Agreement with Amedisys
Highlights Strength of Platform and Track Record of Execution and Value Creation BANNOCKBURN, Ill. , June 26, 2023 /PRNewswire/ -- Option Care Health, Inc. (" Option Care Health " or the "Company") (Nasdaq: OPCH) today announced that it has terminated its previously announced agreement to combine
Toggle Summary Option Care Health Reiterates Value Creation Opportunity of its Previously Announced Definitive Merger Agreement with Amedisys
Issues Statement in Light of Amedisys' Disclosure of Unsolicited Proposal from Optum BANNOCKBURN, Ill. , June 5, 2023 /PRNewswire/ -- Option Care Health, Inc. (" Option Care Health ") (Nasdaq: OPCH) today filed with the U.S. Securities and Exchange Commission a registration statement on Form S-4
Toggle Summary Option Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK™
Company to Deliver to Patients FDA-Approved Topical Treatment for Dystrophic Epidermolysis Bullosa (DEB) Announces Collaboration with Amedisys to Administer Treatment in the Home BANNOCKBURN, Ill. , May 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc.
Toggle Summary Option Care Health to Participate in Upcoming Investor Conferences
BANNOCKBURN, Ill. , May 18, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: William Blair’s 43rd
Toggle Summary Option Care Health to Present at the BofA Securities Health Care Conference
BANNOCKBURN, Ill. , May 05, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will present at the BofA Securities Health Care Conference on Tuesday, May 9, 2023 in
Toggle Summary Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2023
BANNOCKBURN, Ill. , May 3, 2023 /PRNewswire/ -- Option Care Health, Inc. (the "Company" or " Option Care Health ") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2023 .
Toggle Summary Option Care Health and Amedisys to Combine Creating a Leading, Independent Platform for Home and Alternate Site Care
All-Stock Transaction Combines Highly Complementary Businesses Unlocking Significant Benefits for Patients, Providers, Payers, and Care Teams Increases Access to High Quality Care for Communities Across the U.S. through a Unique National Clinical Platform Comprehensive Capabilities Across Alternate